Stock Traders Purchase Large Volume of Rafael Call Options (NYSE:RFL)

Rafael Holdings, Inc. (NYSE:RFL) saw some unusual options trading activity on Tuesday. Investors bought 2,906 call options on the stock. This represents an increase of 329% compared to the typical daily volume of 677 call options.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings upgraded shares of Rafael from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, May 28th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has an average rating of “Sell”.

Institutional Investors Weigh In On Rafael

Hedge funds have recently made changes to their positions in the business. Marshall Wace LLP acquired a new stake in shares of Rafael during the second quarter worth about $50,000. Citadel Advisors LLC raised its stake in Rafael by 132.3% during the 3rd quarter. Citadel Advisors LLC now owns 72,584 shares of the company’s stock valued at $99,000 after acquiring an additional 41,335 shares during the last quarter. Renaissance Technologies LLC raised its stake in Rafael by 59.1% during the 1st quarter. Renaissance Technologies LLC now owns 89,138 shares of the company’s stock valued at $111,000 after acquiring an additional 33,111 shares during the last quarter. Cable Car Capital LP acquired a new stake in Rafael during the 2nd quarter worth approximately $173,000. Finally, Geode Capital Management LLC grew its stake in shares of Rafael by 25.4% in the 4th quarter. Geode Capital Management LLC now owns 445,866 shares of the company’s stock valued at $526,000 after purchasing an additional 90,417 shares during the last quarter. Institutional investors and hedge funds own 11.30% of the company’s stock.

Rafael Stock Performance

NYSE RFL traded up $0.24 on Tuesday, reaching $1.87. The stock had a trading volume of 96,535 shares, compared to its average volume of 81,663. Rafael has a 12-month low of $1.12 and a 12-month high of $3.19. The business’s 50-day moving average price is $1.30 and its 200 day moving average price is $1.28. The stock has a market cap of $97.21 million, a P/E ratio of -2.35 and a beta of 0.54.

Rafael (NYSE:RFL) last announced its earnings results on Monday, March 16th. The company reported ($0.13) earnings per share (EPS) for the quarter. The business had revenue of $0.21 million for the quarter. Rafael had a negative return on equity of 37.27% and a negative net margin of 2,846.60%.

About Rafael

Rafael Holdings, Inc primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), currently under Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia.